
Ciencias de la Vida y Salud
Live pathogens. Pharmaceutical GMP. Both in the same facility — solved by a single engineering team.
Many veterinary projects start from the wrong regulatory standard, conceived for a sector that was once less regulated. Enforced begins by correcting that premise.
The market in detail
Veterinary medicine manufacturers operate under EMA/CVMP GMP requirements alongside biosafety obligations for live pathogens and viral vectors. These are not separate compliance paths — they must be resolved within the same physical environment. Production cleanrooms, formulation areas and BSL-1/2 containment laboratories that satisfy both frameworks in a single qualified facility.
Animal facility projects under Directive 2010/63/EU and FELASA guidelines. For manufacturers destined for the US market, USDA APHIS facility standards integrated into the documentation package. For the Latin American market: SENASICA (Mexico), ICA (Colombia), SENASA (Argentina) and SAG (Chile).